Author: | Spriggs, D. R. |
Article Title: | Discussion |
Keywords: | signal transduction; cancer survival; unclassified drug; gene mutation; gene sequence; sequence analysis; lenalidomide; disease course; cancer growth; note; cancer patient; antineoplastic agent; genetic analysis; phenotype; imatinib; bortezomib; breast cancer; drug screening; oncology; cancer research; temsirolimus; genome analysis; regulatory mechanism; cancer cell; drug response; gefitinib; tumor cell; genomics; outcomes research; malignant neoplastic disease; dna microarray; microenvironment; molecular biology; tumor; oblimersen; human; priority journal; gcs 100; n sec butyl 1 (2 chlorophenyl) n methyl 3 isoquinolinecarboxamide |
Journal Title: | Seminars in Oncology |
Volume: | 31 |
Issue: | Suppl.16 |
ISSN: | 0093-7754 |
Publisher: | Elsevier Inc. |
Date Published: | 2004-12-01 |
Start Page: | 33 |
Language: | English |
DOI: | 10.1053/j.seminoncol.2004.10.017 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Export Date: 16 June 2014 -- CODEN: SOLGA -- Source: Scopus |